Dr. Lattanzi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Texas Oncology - Austin Central 6204 Balcones Drive
Austin, TX 78731Phone+1 512-429-9400Fax+1 512-342-2723- Is this information wrong?
Summary
- Genitourinary Medical Oncology & Clinical Trials
Education & Training
- NYU Grossman School of MedicineResidency, Internal Medicine, 2016 - 2019
- New York University School of MedicineClass of 2016
Certifications & Licensure
- TX State Medical License 2022 - 2025
- NC State Medical License 2022 - 2023
- NY State Medical License 2019 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsClinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience.Brendan J Guercio, Michal Sarfaty, Min Yuen Teo, Neha Ratna, Cihan Duzgol, Samuel A Funt, Chung-Han Lee, David H Aggen, Ashley M Regazzi, Ziyu Chen, Michael Lattanzi, ...> ;Clinical Cancer Research. 2023 Nov 14
- Reply to S. Zhang.Michael Lattanzi, Samuel A Funt, Jonathan E Rosenberg> ;Journal of Clinical Oncology. 2022 Aug 10
- 25 citationsNeoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.Samuel A Funt, Michael Lattanzi, Karissa Whiting, Hikmat Al-Ahmadie, Colleen Quinlan, Min Yuen Teo, Chung-Han Lee, David Aggen, Danielle Zimmerman, Deaglan McHugh, Arl...> ;Journal of Clinical Oncology. 2022 Apr 20
- Join now to see all
Press Mentions
- ESMO 2019: Single Agent Immune Therapy and Immune CombinationsOctober 1st, 2019
- ESMO 2019: TROPHY-U-01: Initial Results of a Phase 2 Open-Label Study of Sacituzumab Givotecan in Patients with Metastatic Urothelial Cancer After Failure of Platinum-Based Regimens or ImmunotherapySeptember 29th, 2019
Hospital Affiliations
- AdventHealth HendersonvilleHendersonville, North Carolina
- Ascension Seton Medical Center AustinAustin, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: